Use of ribavirin and interferon alpha for manufacture pharmaceutical compositions for treating chronic hepatitis C infection

• 收藏
• 分享

专利权人:

MERCK SHARP & DOHME CORP.

发明人:

ALBRECHT JANICE K.

申请号：

SK17102000

公开号：

SK288038B6

申请日:

1999.05.13

申请国别(地区):

SK

年份:

2013

代理人:

摘要：

It is described the use of ribavirin and interferon alpha for the manufacture a pharmaceutical compositions for treating antiviral treatment naive patient having chronic hepatitis C infection to eradicate detectable HCV-RNA involving a combination therapy using a therapeutically effective amount of ribavirin and a therapeutically effective amount of interferon alpha for a time period of from 40 up to 50 weeks.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/